AccuSift High-Performance Influenza B Virus Antibody PairAccuSift provides high-performance Influenza B virus antibody pairs with exceptional lot-to-lot consistency, specifically optimized for the development of IVD kits (Lateral Flow, Chemiluminescence, ELISA, POCT). Featuring high affinity and specificity, they facilitate rapid detection.Influenza B virus is one of the primary pathogens responsible for seasonal influenza. Following viral invasion, the human immune system produces specific antibodies to combat the virus. The core principle of antibody-based detection lies in utilizing specific antibodies to identify and bind to particular antigens of the Influenza B virus (such as the nucleoprotein NP) in samples, or to detect antibodies (IgM or IgG) produced by the body in response to the virus in serum, thereby determining the infection status.IgM Antibodies: These are the first antibodies produced by the immune system after infection. They typically become detectable in the blood 5 to 7 days post-infection. Therefore, an IgM test might be negative during the early stages of illness, necessitating retesting later in the disease course.
- IgG Antibodies: These appear later, usually 7 to 10 days or more after infection, but can persist in the body for an extended period. A positive IgG result at a single time point may only indicate past infection or immune status from vaccination, and cannot confirm a current infection.
- Source: Mouse Monoclonal Antibodies
- Recommended Pairing: YT1101 (Coating) / YT1102 (Labeling)
- Storage: For long-term storage, keep at ≤ -20°C; for short-term storage, keep at 2-8°C. Shipped with ice packs.
WeChat
